Legacy Capital Wealth Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $426K | Sell |
6,174
-404
| -6% | -$27.9K | 0.1% | 226 |
|
|
2025
Q1 | $457K | Buy |
6,578
+1,241
| +23% | +$86.2K | 0.11% | 200 |
|
|
2024
Q4 | $459K | Buy |
5,337
+504
| +10% | +$43.4K | 0.11% | 196 |
|
|
2024
Q3 | $575K | Sell |
4,833
-388
| -7% | -$46.2K | 0.12% | 168 |
|
|
2024
Q2 | $745K | Buy |
+5,221
| New | +$745K | 0.19% | 101 |
|
|
2024
Q1 | – | Sell |
-4,989
| Closed | -$516K | – | 266 |
|
|
2023
Q4 | $516K | Sell |
4,989
-415
| -8% | -$42.9K | 0.15% | 141 |
|
|
2023
Q3 | $491K | Buy |
+5,404
| New | +$491K | 0.13% | 147 |
|
|
2023
Q2 | – | Sell |
-5,566
| Closed | -$443K | – | 168 |
|
|
2023
Q1 | $443K | Buy |
+5,566
| New | +$443K | 0.12% | 146 |
|